Human Metabolome Technologies, Inc. provided consolidated earnings guidance for the year ending June 30, 2022. For the year ending June 30, 2022, the company expects consolidated net sales to be JPY 1,200 million, operating profit to be JPY 100 million, profit attributable to owners of parent to be JPY 100 million and basic earnings per share to be JPY 16.95.